{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:27:53Z","timestamp":1769941673687,"version":"3.49.0"},"reference-count":64,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GOTEL","award":["SCReN,PT13\/PT17\/0017\/0012"],"award-info":[{"award-number":["SCReN,PT13\/PT17\/0017\/0012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The search of prognostic factors is a priority in diffuse large B-cell lymphoma (DLBCL) due to its aggressiveness. We have recently found that the level of circulating MDSCs is a good marker of survival in a translational study based on a trial (EudraCT Number: 2014-001620-29), using lenalidomide combined with R-GDP (rituximab plus gemcitabine, cisplatin, and dexamethasone). Since Vitamin D is a known immunomodulator, we have studied blood levels of these cell populations comparing patients with deficit of vitamin D levels (&lt;15 ng\/mL with those with normal levels &gt;15 ng\/mL. Mann\u2013Whitney U test was used to compare cells distributions between groups, Wilcoxon test to compare cells distribution at different times and Spearman test to measure the association between cell populations. Patients with vitamin D deficit maintained the increased level of immune suppressor cells, whereas we observed a depletion of all immune suppressor cells in patients with normal vitamin D levels. In conclusion, we have confirmed the importance of vitamin D in the response to treatment in R\/R DLBCL, suggesting that vitamin D deficit may be involved in the immune deficit of these patients, and thus, vitamin D supplementation in these patients may help to obtain a better response, warranting further investigation.<\/jats:p>","DOI":"10.3390\/cancers13184622","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T12:00:44Z","timestamp":1631707244000},"page":"4622","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed\/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial"],"prefix":"10.3390","volume":"13","author":[{"given":"Carlos","family":"Jim\u00e9nez-Cortegana","sequence":"first","affiliation":[{"name":"Clinical Laboratory, Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar M.","family":"S\u00e1nchez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Palaz\u00f3n-Carri\u00f3n","sequence":"additional","affiliation":[{"name":"Oncology Service, Department of Medicines, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Nogales-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Oncology Service, Department of Medicines, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Henao-Carrasco","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-1028","authenticated-orcid":false,"given":"Alejandro","family":"Mart\u00edn Garc\u00eda-Sancho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), 37001 Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rueda","sequence":"additional","affiliation":[{"name":"Department of Hematology or Clinical Oncology, Costa del Sol Hospital, M\u00e1laga, 29600 Marbella, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6315-7919","authenticated-orcid":false,"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Puerta de Hierro University Hospital, Majadahonda, 28001 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"de la Cruz-Merino","sequence":"additional","affiliation":[{"name":"Oncology Service, Department of Medicines, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8638-8680","authenticated-orcid":false,"given":"V\u00edctor","family":"S\u00e1nchez-Margalet","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 3139 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/bjh.15412","article-title":"How I manage patients with relapsed\/refractory diffuse large B cell lymphoma","volume":"182","author":"Gisselbrecht","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Solimando, A.G., Annese, T., Tamma, R., Ingravallo, G., Maiorano, E., Vacca, A., Specchia, G., and Ribatti, D. (2020). New insights into diffusse large B-cell lymphoma pathobiology. Cancers, 12.","DOI":"10.20944\/preprints202007.0168.v1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/10408398.2012.688897","article-title":"Vitamin D Bioavailability: State of the Art","volume":"55","author":"Borel","year":"2015","journal-title":"Crit. Rev. Food. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41574-019-0312-5","article-title":"New aspects of vitamin D metabolism and action\u2014Addressing the skin as source and target","volume":"16","author":"Bikle","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1017\/S0007114516000696","article-title":"Vitamin D and colorectal cancer: Molecular, epidemiological, and clinical evidence","volume":"115","author":"Dou","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.21873\/anticanres.13976","article-title":"Relevance of Vitamin D in Melanoma Development, Progression and Therapy","volume":"40","author":"Hoffman","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_8","first-page":"1","article-title":"Vitamin D and Lung Cancer; Association, Prevention, and Treatment","volume":"11","author":"Wang","year":"2020","journal-title":"Nutr. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/CEJ.0000000000000167","article-title":"Pancreatic cancer control: Is vitamin D the answer?","volume":"25","author":"Iqbal","year":"2016","journal-title":"Eur. J. Cancer. Prev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jsbmb.2017.07.025","article-title":"Vitamin D and breast cancer: Past and present","volume":"177","author":"Welsh","year":"2018","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00432-014-1706-3","article-title":"Positive association between circulating 25-hydroxivitamin D levels and prostate cancer risk: New findings from an updated meta-analysis","volume":"140","author":"Xu","year":"2014","journal-title":"J. Cancer. Res. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00432-020-03125-w","article-title":"25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma","volume":"146","author":"Xu","year":"2020","journal-title":"J. Cancer. Res. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2014.57.5092","article-title":"Low serum vitamin D levels are associated with inferior survival in Follicular Lymphoma: A prospective evaluation in SWOG and LYSA Studies","volume":"33","author":"Kelly","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"300060520943421","DOI":"10.1177\/0300060520943421","article-title":"Vitamin D levels in patients with non-Hodgkin lymphoma\/diffuse large B-cell lymphoma, chronic lymphocytic leukemia and multiple myeloma","volume":"48","author":"Graklanov","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clnu.2020.04.040","article-title":"Bioavailable 25(OH)D level is associated with clinical outcomes of patients with diffuse large B-cell lymphoma: An exploratory study","volume":"40","author":"Chen","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: A review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/annonc\/mdv102","article-title":"A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma","volume":"26","author":"Witzig","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cam4.1166","article-title":"Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunotherapy","volume":"7","author":"Hohaus","year":"2018","journal-title":"Cancer. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1038\/cddis.2014.346","article-title":"Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK","volume":"5","author":"Brosseau","year":"2014","journal-title":"Cell. Death. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00262-018-2224-y","article-title":"Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity","volume":"67","author":"Neumann","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18632\/oncotarget.26531","article-title":"Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango","volume":"10","author":"Flamann","year":"2019","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12185-020-02989-5","article-title":"Complete metabolic remission in an 84-year old patient with relapsed\/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab","volume":"112","author":"Tomuleasa","year":"2020","journal-title":"Int. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/15384047.2018.1449609","article-title":"Lenalidomide combined with R-GDP in a patient with refractory CD5-positive diffuse large B-cell lymphoma: A promising response and review","volume":"19","author":"Zhang","year":"2018","journal-title":"Cancer Biol. Ther"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hon.67_2630","article-title":"Lenalidomide plus R-GDP (R2-GDP) in relapsed\/refractory diffuse large B-cell lymphoma. Preliminary results of the R2-GDP-GOTEL trial","volume":"37","author":"Guma","year":"2019","journal-title":"Hematol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1200\/JCO.2020.38.15_suppl.8019","article-title":"Lenalidomide plus R-GDP (R2-GDP) in relapsed\/refractory diffuse large B-cell lymphoma: Final results of the R2-GDP-GOTEL trial","volume":"38","author":"Guma","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e002323","DOI":"10.1136\/jitc-2020-002323","article-title":"Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory\/relapsed diffuse large B-cell lymphoma: Translational results from the R2-GDP-GOTEL trial","volume":"9","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J. Investig. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: Modulator of the immune system","volume":"10","author":"Beake","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.jsbmb.2019.105557","article-title":"1a, 25 Dihydroxyvitamin D (1,25(OH)2 D) inhibits the T cell suppressive functions of myeloid derived suppressor cells (MDSC)","volume":"198","author":"Fleet","year":"2020","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00262-017-1977-z","article-title":"Myeloid cells in circulation and tumor microenvironment of breast cancer patients","volume":"66","author":"Toor","year":"2017","journal-title":"Cancer. Immunol. Immunother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2040620716673787","article-title":"Emerging role of checkpoint blockade therapy in lymphoma","volume":"8","author":"Galanina","year":"2017","journal-title":"Ther. Adv. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.4049\/jimmunol.1200786","article-title":"Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses","volume":"189","author":"Jeffery","year":"2012","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24177","DOI":"10.18632\/oncotarget.15489","article-title":"Vitamin D increases programmed death receptor-1 expression in Crohn\u2019s disease","volume":"8","author":"Bendix","year":"2017","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cei.12984","article-title":"Vitamin D treatment modulates immune activation in cystic fibrosis","volume":"189","author":"Pincikova","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_36","first-page":"191","article-title":"The relationship of solar radiation to cancer mortality in North America","volume":"1","author":"Apperly","year":"1941","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/9.3.227","article-title":"Do sunlight and vitamin D reduce the likelihood of colon cancer?","volume":"9","author":"Garland","year":"1980","journal-title":"Int. J. Epidemiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.annepidem.2008.12.014","article-title":"Ecological studies of ultraviolet B, vitamin D and cancer since 2000","volume":"19","author":"Grant","year":"2009","journal-title":"Ann. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/epirev\/mxx005","article-title":"Vitamin D and cancer risk and mortality: State of the science, gaps, and challenges","volume":"39","author":"Mondul","year":"2017","journal-title":"Epidemiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3109\/13880209.2014.988274","article-title":"Vitamin D in cancer chemoprevention","volume":"53","author":"Giammanco","year":"2015","journal-title":"Pharm. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/jca.1.101","article-title":"Vitamin D in combination cancer treatment","volume":"1","author":"Ma","year":"2010","journal-title":"J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s12276-018-0038-9","article-title":"Exploring vitamin D metabolism and function in cancer","volume":"50","author":"Jeon","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1200\/JCO.2013.53.4537","article-title":"Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab","volume":"32","author":"Bittengring","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00277-020-04200-5","article-title":"The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma","volume":"99","author":"Wang","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/nu5072502","article-title":"Vitamin D and immune function","volume":"5","author":"Prietl","year":"2013","journal-title":"Nutrients"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2011.03482.x","article-title":"Vitamin D3: A helpful immuno-modulator","volume":"134","author":"Malaquarnera","year":"2011","journal-title":"Immunology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-Derived Suppressor Cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer. Immunol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/jcp.25016","article-title":"Treg(s) in Cancer: Friends or Foe?","volume":"230","author":"Wolf","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 immune checkpoint: Potential target for cancer therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: A moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1158\/1078-0432.CCR-15-0200","article-title":"Lenalidomide enhances immune checkpoint blockade induced immune response in multiple myeloma","volume":"21","author":"Samur","year":"2015","journal-title":"Clin. Cancer. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-019-0797-3","article-title":"Myeloid-derived suppressor cells in hematological malignancies: Friends or foes","volume":"12","author":"Lv","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"547697","DOI":"10.1155\/2015\/547697","article-title":"Vitamin D deficiency contributes to the reduction and impaired function of CD45RA+ na\u00efve regulatory T cell in chronic heart failure","volume":"2015","author":"Ma","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1426503","DOI":"10.1155\/2016\/1426503","article-title":"Dietary vitamin D increases percentages and function of regulatory T cells in the skin-draining lymph nodes and suppresses dermal inflammation","volume":"2016","author":"Gorman","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/09540105.2015.1109612","article-title":"Immunomodulatory vitamin D effects on regulatory T-cells and cytokines in an in vitro study on patients with systemic lupus erythematosus","volume":"27","author":"Ghoryani","year":"2016","journal-title":"Food. Agric. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Fisher, S.A., Rahimzadeh, M., Brierley, C., Gration, B., Doree, C., Kimber, C.E., Plaza-Cajide, A., Lamikanra, A.A., and Roberts, D.J. (2019). The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222313"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2567.2011.03507.x","article-title":"1,25-dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells","volume":"134","author":"Khoo","year":"2011","journal-title":"Immunology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3389\/fimmu.2019.01307","article-title":"Vitamin D controls tumor growth and CD8+ T cell infiltration in breast cancer","volume":"10","author":"Karkeni","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"20657","DOI":"10.1074\/jbc.M117.793885","article-title":"Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice","volume":"292","author":"Dimitrov","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-Dihidroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FOXP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Jeffery, L.E., Qureshi, O.S., Gardner, D., Hou, T.Z., Briggs, Z., Soskic, B., Baker, J., Raza, K., and Sansom, D.M. (2015). Vitamin D antagonises the suppressive effect of inflammatory cytokines on CTLA-4 expression and regulatory function. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131539"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hon.2827","article-title":"Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin\u2019s and diffuse large B-cell lymphoma","volume":"39","author":"Donati","year":"2021","journal-title":"Hematol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Martens, P.-J., Gysemans, C., Verstuyf, A., and Mathieu, C. (2020). Vitamin D\u2019s effect on immune function. Nutrients, 12.","DOI":"10.3390\/nu12051248"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4622\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:00:04Z","timestamp":1760166004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":64,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cancers13184622"],"URL":"https:\/\/doi.org\/10.3390\/cancers13184622","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]}}}